cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Biohaven Pharmaceutical Holding Company Ltd
8 own
14 watching
Current Price
$19.17
$0.35
(1.86%)
logo-bhvn
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,306.65M
52-Week High
52-Week High
20.57
52-Week Low
52-Week Low
5.54
Average Volume
Average Volume
1.5M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,306.65M
icon52-Week High20.57
icon52-Week Low5.54
iconAverage Volume1.5M
iconDividend Yield--
iconP/E Ratio--
What does the Biohaven Pharmaceutical Holding Company Ltd do?
N/A
Read More
How much money does Biohaven Pharmaceutical Holding Company Ltd make?
News & Events about Biohaven Pharmaceutical Holding Company Ltd.
PR Newswire
28days ago
Biohaven to Present at the 41st Annual J.P. Morgan Healthcare Conference Biohaven to Present at the 41st Annual J.P. Morgan Healthcare Conference PR Newswire NEW HAVEN, Conn., Jan. 6, 2023 NEW HAVEN, Conn., Jan. 6, 2023 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN) today announced thatVlad Coric...
Globe Newswire
1month ago
Mike Heffernan appointed Chairman of NMD Pharmas Board of Directors Brings 30 years of experience building private and public development-stage and commercial biopharmaceutical companies and has overseen several successful IPOs and trade sales Aarhus, Denmark, 3 January 2023 NMD Pharma A/S, a ...
PR Newswire
3 months ago
Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares PR Newswire NEW HAVEN, Conn., Oct. 25, 2022 NEW HAVEN...
PR Newswire
3 months ago
Biohaven Announces Pricing of Public Offering of Common Shares Biohaven Announces Pricing of Public Offering of Common Shares PR Newswire NEW HAVEN, Conn., Oct. 20, 2022 NEW HAVEN, Conn., Oct. 20, 2022 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN) ('Biohaven') announced today the pricing of...
Business Wire
4 months ago
Pfizer Inc. (NYSE: PFE) announced today the completion of its acquisition of Biohaven Pharmaceutical Holding Company Ltd., the maker of NURTEC ODT (rimegepant), an innovative migraine therapy approved for both acute treatment and prevention of episodic migraine in adults. The acquisition brings to...
Frequently Asked Questions
Frequently Asked Questions
What is Biohaven Pharmaceutical Holding Company Ltd share price today?
plus_minus_icon
Can Indians buy Biohaven Pharmaceutical Holding Company Ltd shares?
plus_minus_icon
How can I buy Biohaven Pharmaceutical Holding Company Ltd shares from India?
plus_minus_icon
Can Fractional shares of Biohaven Pharmaceutical Holding Company Ltd be purchased?
plus_minus_icon
What are the documents required to start investing in Biohaven Pharmaceutical Holding Company Ltd stocks?
plus_minus_icon
What is today’s traded volume of Biohaven Pharmaceutical Holding Company Ltd?
plus_minus_icon
What is today’s market capitalisation of Biohaven Pharmaceutical Holding Company Ltd?
plus_minus_icon
What is the 52-Week High and Low Range of Biohaven Pharmaceutical Holding Company Ltd?
plus_minus_icon
What percentage is Biohaven Pharmaceutical Holding Company Ltd down from its 52-Week High?
plus_minus_icon
What percentage is Biohaven Pharmaceutical Holding Company Ltd up from its 52-Week Low?
plus_minus_icon
Current Price
$19.17
$0.35
(1.86%)
logo-bhvn
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc
$20.12
$0.12 (0.60 %)
Morphic Holding Inc
Morphic Holding Inc
$34.34
$0.63 (1.87 %)
Cassava Sciences Inc
Cassava Sciences Inc
$31.52
$2.72 (9.44 %)
Replimune Group Inc
Replimune Group Inc
$29.09
$0.50 (1.75 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc
$20.12
$0.12 (0.60 %)
Morphic Holding Inc
Morphic Holding Inc
$34.34
$0.63 (1.87 %)
Cassava Sciences Inc
Cassava Sciences Inc
$31.52
$2.72 (9.44 %)
Replimune Group Inc
Replimune Group Inc
$29.09
$0.50 (1.75 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00